The price gouging pharmaceutical CEO Martin Shkreli had the smirk wiped from his face today when he was arrested by the FBI for securities fraud. The investigation, in which Mr. Shkreli has been charged with securities fraud, is related to his time as a hedge fund manager and running the biopharmaceutical company Retrophin — not …
